您当前的位置：
首页 >
文章列表页 >
Mechanisms of Dihuang Yinzi in Treating Advanced Parkinson's Disease Based on Gut Microbiota-SCFAs-inflammation Axis
更新时间：2026-03-03

    • Mechanisms of Dihuang Yinzi in Treating Advanced Parkinson's Disease Based on Gut Microbiota-SCFAs-inflammation Axis

      增强出版
    • “Expert research has found that Dihuang Yinzi can improve motor disorders in late stage Parkinson's disease rats by regulating intestinal microbiota SCFAs inflammation and exerting therapeutic effects”
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 32, Issue 7, Pages: 11-21(2026)

    • DOI：10.13422/j.cnki.syfjx.20252401    

      CLC： R289;R259;R285

    • Received：27 August 2025，

      Revised：2025-10-29，

      Accepted：30 October 2025，

      Online First：03 November 2025，

      Published：05 April 2026

    移动端阅览

  • MA Renzhi,LIN Yasi,JIANG Tingyue,et al.Mechanisms of Dihuang Yinzi in Treating Advanced Parkinson's Disease Based on Gut Microbiota-SCFAs-inflammation Axis[J].Chinese Journal of Experimental Traditional Medical Formulae,2026,32(07):11-21. DOI： 10.13422/j.cnki.syfjx.20252401.

  •  
  •  

0

Views

23

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Dictamnine Induces Liver Injury via Gut Microbiota-bile Acid Axis
Fufang Kangjiaolv Capsules Treat Anxiety in Rat Model of Chronic Restraint Stress via Microbiota-gut-brain Axis
Effect of Huangqintang on Inflammation and Short-chain Fatty Acid-related Gut Microbiota in Mouse Model of Inflammation-associated Colorectal Cancer

Related Author

LIU Sujie
RUAN Jiaxin
WANG Chen
WANG Xiaofan
YAN Jiahe
WANG Yu
LU Fang
LIU Shumin

Related Institution

Graduate School，Heilongjiang University of Chinese Medicine
Institute of Traditional Chinese Medicine，Heilongjiang University of Chinese Medicine
Institute of Chinese Materia Medica，China Academy of Chinese Medical Sciences
Heilongjiang University of Chinese Medicine
institute of Shanghai Universities,Division of Nitric Oxide and Inflammatory Medicine,Shanghai
0